MedCity Pivot Podcast: How the Right Payment Tech Can Foster Better Payer-Provider Relationships
Yusuf Qasim, president of payments optimization at Zelis, talks about how his company’s platform is seeking to rebuild the healthcare payment process. The platform aims to eliminate unnecessary manual work for both payers and providers. Watch or listen now! The post MedCity Pivot Podcast: How the Right Payment Tech Can Foster Better Payer-Provider Relationships appeared…
Adapting Healthcare Payments While Facing Financial Pressure and Economic Uncertainty
Practices that embrace automation, interoperability, and consumer-grade payment experiences will reduce risk, strengthen cash flow, and build lasting trust with the patients they serve. Those that delay will continue absorbing avoidable costs and volatility. The post Adapting Healthcare Payments While Facing Financial Pressure and Economic Uncertainty appeared first on MedCity News.
AHA Invests in AI that Tackles Cardiology’s Gender Bias Problem
The American Heart Association is backing an AI startup aimed at improving detection of hard-to-diagnose conditions like cardiac amyloidosis and heart failure with preserved ejection fraction (HFpEF). The company, named Ultromics, offers a platform that analyzes routine echocardiograms to help clinicians catch disease earlier, particularly for women who are more likely to be missed. The…
Proposed Federal Budget Includes Major Cuts to Healthcare Funding
Critics warn that these cuts could weaken public health infrastructure and reduce access to essential services for Americans
You, Me, and Our Microbiome
By KIM BELLARD You may have heard about the microbiome, that collection of microorganisms that fill the world around, and in, us. You may have had some digestive tract issues after a round of antibiotics wreaked havoc with your gut microbiome. You may have read about the rafts of research that are making it clearer…
This HIV Expert Refused To Censor Data, Then Quit the CDC
John Weiser, a doctor and researcher, has treated people with HIV since the beginning of the AIDS epidemic in the 1980s. He joined the CDC’s HIV prevention team in 2011 to help lead its Medical Monitoring Project, the only in-depth survey of HIV across the United States. The project has shaped the country’s response to…
New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds
Eli Lilly drug Ebglyss is now FDA-approved for atopic dermatitis, an inflammatory skin disorder also known as eczema. The biologic drug came from Lilly’s $1.1 billion acquisition of Dermira in 2020. The post New Eli Lilly Eczema Drug Brings Competition and Dosing Edge Versus Sanofi, LEO Pharma Meds appeared first on MedCity News.
A New Prescription for Hyperemesis Gravidarum: Why We Should Rethink “Morning Sickness”
Far more severe than typical “morning sickness,” HG locks women in a debilitating cycle of nausea, vomiting, and dehydration, which can lead to serious health complications, including weight loss, neurological defects in infants, and even maternal suicide. The post A New Prescription for Hyperemesis Gravidarum: Why We Should Rethink “Morning Sickness” appeared first on MedCity…
Report: Immigrants in NYC Have Higher Life Expectancy Than U.S.-Born People
The NYC Health Department released a report highlighting the immigrant contributions to the city’s health